Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
about
The changing disease-scape in the third epidemiological transitionGFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of HerpesRegional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, CanadaAn estimate of the global prevalence and incidence of herpes simplex virus type 2 infectionThe seroepidemiology of herpes simplex virus type 1 and 2 in EuropeSeroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based studyWater dispersible microbicidal cellulose acetate phthalate filmMacrophages and cytokines in the early defence against herpes simplex virusDetection, quantification and genotyping of Herpes Simplex Virus in cervicovaginal secretions by real-time PCR: a cross sectional surveyHuman Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionEpidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.Herpes simplex virus infections among rural residents in eastern China.Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance controlIncreasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmesSexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosumA comparison of referral patterns and characteristics of patients with first episode symptomatic genital HSV-1 and HSV-2 infections in Sheffield.Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study GroupValaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study GroupEvaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient populationRecent advances in management of genital herpes.Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolatesCellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.Sorting out the new HSV type specific antibody tests.The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferonEpidemiological impact of a genital herpes type 2 vaccine for young females.A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNAMature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.A survey on herpes simplex type 2 antibody among pregnant women in Isfahan, IranUsing the evidence base on genital herpes: optimising the use of diagnostic tests and information provision.Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in TanzaniaIdentity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursorsHerpes simplex virus infections of women and their offspring: implications for a developed society.Barrier to auto integration factor becomes dephosphorylated during HSV-1 Infection and Can Act as a host defense by impairing viral DNA replication and gene expression
P2860
Q17485683-5E47077D-8052-4219-9DEB-1A3C43D7919EQ21254674-86965D88-4083-4942-AD90-098083202DC8Q24550624-D745B0A1-4099-423C-A005-8C3DA35C2D6CQ24646809-42B10285-30AF-460A-ABC6-FCBE825A13C2Q24679583-E80788E0-0AAD-4330-A8B3-48D629D08E11Q24791873-1B801D8D-9604-4CC7-A215-EBAE40593DF2Q24799617-39E0EFE5-CF44-4CD4-AF79-7C345CA6E13AQ24815062-D98683E7-D5D5-49C1-833D-41032EC35302Q24816175-7183A0CB-7020-4950-A381-270B5CD1A8D9Q26751304-D6975651-16F9-4981-8D7B-DD5F48AFC490Q30234429-EB08FE82-0789-4F28-BDFD-9DCFFB1182B8Q33336603-CECB9267-5A7A-413B-BD58-1D737614231DQ33749597-B736DFA0-217E-498C-A1B8-9C30416CA1AAQ33782992-244CCDE1-D430-40BB-B338-610B4CED482FQ33849495-5011A6C6-2F0E-4CB4-850A-D59681D46412Q33882404-07C63935-7A3F-4E25-BBB4-0A086953D965Q33885705-416BEFC7-DAEE-48A3-8A7C-244B2F69EA5FQ33934491-0F6CF2C2-F903-4BA6-BC5B-2D3AD8950EFFQ33936150-69C0B616-A17F-4166-8C77-3175D8E22E28Q33936572-9198A662-4EA6-4982-A440-B0BB0CCDA50CQ33936578-8492CEE6-5860-4A45-A428-55BE30B3FFE4Q33959969-6865AECC-FB0C-4079-9E61-EE1BAFAE09FCQ33973461-5AA0EFC2-F604-4F9B-9B17-4096B54871D3Q34012149-CF09EAC1-39E0-4CDC-A307-4A623D0997FAQ34073676-2EAA5849-2586-499C-B3CE-754AB29D257AQ34193783-6F97FA9C-9405-4D16-BAB1-1EDEAA010AF6Q34307385-DC451A4E-1A61-48CE-B882-ECF8B3914AA6Q34313806-E57A909A-A38A-4CD0-AAD2-EBC2EFC3D14BQ34344812-AEEF5B32-E616-4646-BE92-5F0D889BAB3FQ34446935-D6A63799-C54D-4476-A34E-06E2C8C3C004Q34465399-FFA4057D-142A-42BF-B660-1C4589686646Q34648195-4FC905D5-4129-4D46-9C7E-D06C7618ECBEQ34720324-66D05217-5776-4F9B-990B-C02A8196FEF2Q34864171-D6533362-F9D2-46E8-B305-2846C64816DFQ34868359-9EA20F90-5810-4EAB-A2CA-CFD73AE039A9Q34942862-CE1614A8-19DE-42F1-A8DC-2B26820FE265Q35073056-478E84E0-F1D9-46B0-B976-F582539A4C96Q35111489-E6754532-D0DD-4CC5-AFF9-4C13C12421F6Q35114519-8BBB015B-179C-467E-A4DA-1DDCD0B4A081Q35191248-090CB4CE-C6BF-436F-A588-0E1391A17608
P2860
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sero-epidemiological and -soci ...... virus infection in the world.
@en
Sero-epidemiological and -soci ...... virus infection in the world.
@nl
type
label
Sero-epidemiological and -soci ...... virus infection in the world.
@en
Sero-epidemiological and -soci ...... virus infection in the world.
@nl
prefLabel
Sero-epidemiological and -soci ...... virus infection in the world.
@en
Sero-epidemiological and -soci ...... virus infection in the world.
@nl
P2093
P1476
Sero-epidemiological and -soci ...... virus infection in the world.
@en
P2093
A J Nahmias
S Beckman-Nahmias
P577
1990-01-01T00:00:00Z